Captor Therapeutics
Wroclaw · Founded 2017
About Captor Therapeutics
Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases. Targeted Protein Degradation (TPD) combats the therapeutic limits of small molecules with overcoming drug resistance and uncoupling their pharmacokinetics from pharmacodynamics. Breakthrough TPD technology allows degradation of virtually any intracellular protein including the so-called "undruggable proteome".
Company Facts
- Founded: 2017
- Legal name: Captor Therapeutics SA
- Operating status: IPO
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $17.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2026)
- Website: captortherapeutics.com
- Phone: +48 537 869 089
Social Profiles
Canonical: https://fsome.com/organization/captor-therapeutics-8336090 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.